| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-8993(93)90210-E |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000689939390210E?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:000689939390210E?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 7689410 |
| P2093 | author name string | H. K. Proudfit | |
| F. M. Clark | |||
| P2860 | cites work | EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS | Q28201187 |
| Catecholamine innervation of the caudal spinal cord in the rat. | Q36501735 | ||
| The projections of locus coeruleus neurons to the spinal cord | Q37042662 | ||
| Background staining and sensitivity of the unlabelled antibody-enzyme (PAP) method. Comparison with the peroxidase labelled antibody sandwich method using formalin fixed paraffin embedded material | Q39337446 | ||
| Peripheral and spinal mechanisms of nociception | Q39755865 | ||
| Immunofluorescence of dopamine- -hydroxylase. Application of improved methodology to the localization of the peripheral and central noradrenergic nervous system | Q39868695 | ||
| An anterograde neuroanatomical tracing method that shows the detailed morphology of neurons, their axons and terminals: Immunohistochemical localization of an axonally transported plant lectin,Phaseolus vulgaris leucoagglutinin (PHA-L) | Q41807190 | ||
| Funicular course of catecholamine fibers innervating the lumbar spinal cord of the cat. | Q43523497 | ||
| Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons | Q44890627 | ||
| The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry | Q44906992 | ||
| Afferent and efferent connections of the A5 noradrenergic cell group in the rat. | Q46037542 | ||
| Origin and organization of brainstem catecholamine innervation in the rat. | Q46116115 | ||
| Distribution of locus coeruleus axons in the rat spinal cord: a combined anterograde transport and immunohistochemical study | Q48170260 | ||
| Descending noradrenergic pathways involved in the A5 depressor response | Q48286516 | ||
| Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat | Q48483028 | ||
| Electrophysiological properties of spinally-projecting A5 noradrenergic neurons | Q48657466 | ||
| The noradrenergic innervation of the spinal cord: differences between two substrains of Sprague-Dawley rats determined using retrograde tracers combined with immunocytochemistry | Q48737633 | ||
| Characterization of descending modulation of nociception from the A5 cell group | Q48738664 | ||
| Antagonism of stimulation-produced antinociception from ventrolateral pontine sites by intrathecal administration of alpha-adrenergic antagonists and naloxone | Q48879655 | ||
| Descending Noradrenergic Projections and their Spinal Terminations | Q49103984 | ||
| Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn | Q49131262 | ||
| The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord. | Q50888678 | ||
| Significant differences in the retrograde labeling of spinothalamic tract cells by horseradish peroxidase and the fluorescent tracers fast blue and diamidino yellow. | Q50890780 | ||
| Noradrenergic neurons with divergent projections to the motor trigeminal nucleus and the spinal cord: a double retrograde neuronal labeling study. | Q50894998 | ||
| Direct projections from the A5 catecholamine cell group to the intermediolateral cell column | Q66939887 | ||
| Electrophysiological evidence that the A5 catecholamine cell group is a vasomotor center | Q66956605 | ||
| The effects of stimulation of the A5 region on blood pressure and heart rate in rabbits | Q68084285 | ||
| Spinally projecting noradrenergic neurons of the dorsolateral pontine tegmentum: a combined immunocytochemical and retrograde labeling study | Q69373000 | ||
| The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry | Q70135368 | ||
| Origins and terminations of descending noradrenergic projections to the spinal cord of monkey | Q70322091 | ||
| Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry | Q71507029 | ||
| Noradrenergic projections to the spinal cord of the rat | Q71703140 | ||
| Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-β-hydroxylase | Q72648228 | ||
| CELLULAR LOCALIZATION OF MONOAMINES IN THE SPINAL CORD | Q76758709 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sensory perception of pain | Q2734305 |
| stilbamidine | Q67582890 | ||
| P304 | page(s) | 200-210 | |
| P577 | publication date | 1993-07-01 | |
| 1993-07-09 | |||
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception | |
| P478 | volume | 616 |
| Q34464747 | A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain |
| Q33734909 | A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. |
| Q44138655 | A5 cells are silenced when REM sleep-like signs are elicited by pontine carbachol |
| Q31140350 | Age-associated changes in the monoaminergic innervation of rat lumbosacral spinal cord |
| Q41091508 | An ascending general homeostatic afferent pathway originating in lamina I. |
| Q36982694 | Antidepressant agents for the treatment of chronic pain and depression |
| Q34607230 | Antidepressants in the treatment of fibromyalgia |
| Q44182846 | Antinociception from lateral hypothalamic stimulation may be mediated by NK(1) receptors in the A7 catecholamine cell group in rat. |
| Q24684137 | Biology and therapy of fibromyalgia. New therapies in fibromyalgia |
| Q74039052 | Calbindin-immunoreactive neurons in the reticular formation of the rat brainstem: catecholamine content and spinal projections |
| Q73019382 | Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach |
| Q33711494 | Central mechanisms of pain modulation |
| Q52163159 | Central nervous system structures labelled from the testis using the transsynaptic viral tracing technique. |
| Q48161672 | Cross over of forebrain and brainstem neuronal projections to spinal cord sympathetic preganglionic neurons in the rat. |
| Q43594427 | Descending supraspinal pathways in amphibians. II. Distribution and origin of the catecholaminergic innervation of the spinal cord |
| Q37178229 | Developmental profiles of neurotransmitter receptors in respiratory motor nuclei |
| Q43739603 | Differential expression of catecholamine synthetic enzymes in the caudal ventral pons |
| Q36953559 | Distribution of catecholaminergic presympathetic-premotor neurons in the rat lower brainstem |
| Q37263414 | Duloxetine for neuropathic pain based on recent clinical trials |
| Q39332427 | Duloxetine for the management of diabetic peripheral neuropathic pain: response profile |
| Q37663562 | Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial |
| Q43639928 | Effect of embryonic knock-down of GABAA receptors on the levels of monoamines and their metabolites in the CNS of the mouse |
| Q48601596 | Effect of lesion of a5 and a7 brainstem noradrenergic areas or transection of brainstem pathways on sympathoadrenal activity in rats during immobilization stress |
| Q44590402 | Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception |
| Q53849078 | Efferent control of different visceral pelvic organs by spinal and supraspinal centres. |
| Q64953506 | Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. |
| Q47393626 | Elimination of the post-hypoxic frequency decline in conscious rats lesioned in pontine A5 region |
| Q48522566 | Enkephalin neurons that project to the A7 catecholamine cell group are located in nuclei that modulate nociception: ventromedial medulla |
| Q46517235 | Estrogen receptor-alpha and -beta immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems |
| Q45917959 | Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. |
| Q37863057 | Fibromyalgia and obesity: the hidden link |
| Q36600398 | Fos expression in pontomedullary catecholaminergic cells following rapid eye movement sleep-like episodes elicited by pontine carbachol in urethane-anesthetized rats |
| Q32160952 | Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation |
| Q36118150 | Inhibition of A5 Neurons Facilitates the Occurrence of REM Sleep-Like Episodes in Urethane-Anesthetized Rats: A New Role for Noradrenergic A5 Neurons? |
| Q96823196 | Input-output connections of LJA5 prodynorphin neurons |
| Q37227196 | Inputs to serotonergic neurons revealed by conditional viral transneuronal tracing |
| Q58251507 | Lesions of the caudal ventrolateral medulla block the hypertension-induced inhibition of noxious-evoked c-fos expression in the rat spinal cord |
| Q48595505 | Lumbar but not cervical intrathecal DAMGO suppresses extrasegmental nociception in awake rats |
| Q74340361 | Medullary monoamine levels during experimental tooth movement |
| Q46739167 | Midbrain periaqueductal gray (PAG) inhibits nociceptive inputs to sacral dorsal horn nociceptive neurons through alpha2-adrenergic receptors |
| Q43792327 | Modulatory actions of serotonin, norepinephrine, dopamine, and acetylcholine in spinal cord deep dorsal horn neurons |
| Q34590416 | Neurobiology of nitrous oxide-induced antinociceptive effects |
| Q34080392 | Neuronal lesioning with axonally transported toxins |
| Q48559115 | Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats |
| Q48443963 | Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain |
| Q35808913 | Presynaptic Inputs to Any CNS Projection Neuron Identified by Dual Recombinant Virus Infection |
| Q36836826 | Projections from the rat cuneiform nucleus to the A7, A6 (locus coeruleus), and A5 pontine noradrenergic cell groups. |
| Q42553132 | Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo |
| Q73798766 | Role of spinal GABA receptors in depressor responses to chemical stimulation of the A5 area in normal and hypertensive rats |
| Q33577285 | Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials |
| Q33469649 | Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials |
| Q28255560 | Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats |
| Q33588319 | Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan |
| Q48259363 | The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group |
| Q79301113 | The challenge of defining brainstem pain modulation circuits |
| Q60678928 | The dissociation of sedative from spinal antinociceptive effects following administration of a novel alpha-2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat |
| Q48535301 | The pontine A5 noradrenergic cells which project to the spinal cord dorsal horn are reciprocally connected with the caudal ventrolateral medulla in the rat. |
| Q45787693 | Transneuronal labeling of neurons in the adult rat brainstem and spinal cord after injection of pseudorabies virus into the urethra |
| Q36380212 | Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo |
| Q48726355 | Trigeminal autonomic pathways involved in nociception-induced reflex cardiovascular responses |
| Q35191443 | Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients |
| Q36309856 | Ultrastructural analysis of rat ventrolateral periaqueductal gray projections to the A5 cell group. |
| Q77953662 | Ultrastructural evidence that substance P neurons form synapses with noradrenergic neurons in the A7 catecholamine cell group that modulate nociception |
| Q33606487 | Visualizing acute pain-morphine interaction in descending monoamine nuclei with Fos |
| Q30464930 | Working model of the sympathetic chemoreflex in rats |
Search more.